(FM) Neurología
Departamento académico
![Foto de (FM) Neurología](/img/uploaded/917D78EB177071228AD05EA844F64872.jpg)
![Foto de Hospital Universitario de la Princesa](/img/noimage_org.png)
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (27)
2024
-
Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment
Medicina Clinica
-
Nueva era terapéutica para el ataque de migraña con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes
Revista de neurologia, Vol. 78, Núm. 2, pp. 47-57
2023
-
Hemihypomimia in Parkinson’s disease: an under-recognized clinical sign?
Journal of Neurology
-
Medical help-seeking intentions among patients with early Alzheimer’s disease
Frontiers in Psychiatry, Vol. 14
-
Recomendaciones de consenso para el tratamiento de la prevención de la migraña
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
-
[Translated article] Consensus recommendations on the preventive treatment of migraine
Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T246-T253
2022
-
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
-
Cutaneous Allodynia in Migraine: A Narrative Review
Frontiers in Neurology, Vol. 12
-
Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy
Epilepsy and Behavior, Vol. 137
-
Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease
Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726
-
Trial of Prasinezumab in Early-Stage Parkinson's Disease
New England Journal of Medicine, Vol. 387, Núm. 5, pp. 421-432
2021
-
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Neurology, Vol. 97, Núm. 14, pp. E1367-E1381
-
Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project
Brain Sciences, Vol. 11, Núm. 8
-
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
Neurologia, Vol. 36, Núm. 8, pp. 611-617
2020
-
Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
European Journal of Neurology, Vol. 27, Núm. 10, pp. 2102-2108
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
2019
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
2018
-
Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study
Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335